Rachel Lenington

Insider Reports History

Entity
Individual
Location
C/O Athira Pharma, Inc., 18706 North Creek Parkway, Suite 104, Bothell, WA
Signature
/s/ Mark Worthington, Attorney-in-Fact for Rachel Lenington
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Rachel Lenington:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Athira Pharma, Inc. COO and CDO Common Stock 20.9K $11.8K $0.57 Sep 5, 2024 Direct
Athira Pharma, Inc. COO and CDO Stock Option (Right to Buy) 300K Feb 14, 2024 Direct

Insider Reports Filed by Rachel Lenington

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ATHA Athira Pharma, Inc. Sep 3, 2024 2 -$1.43K 4 Sep 5, 2024 COO and CDO
ATHA Athira Pharma, Inc. Feb 14, 2024 1 $0 4 Feb 16, 2024 COO AND CDO
ATHA Athira Pharma, Inc. Jan 4, 2024 2 -$7.02K 4/A Feb 16, 2024 COO AND CDO
ATHA Athira Pharma, Inc. Jan 4, 2024 2 -$7.02K 4 Jan 8, 2024 Chief Operating Officer
ATHA Athira Pharma, Inc. Jan 19, 2023 1 $0 4 Jan 23, 2023 Chief Operating Officer
ATHA Athira Pharma, Inc. Jun 22, 2022 2 -$11.3K 4 Jun 24, 2022 Chief Operating Officer
ATHA Athira Pharma, Inc. Jan 18, 2022 1 $0 4 Jan 20, 2022 Chief Operating Officer
ATHA Athira Pharma, Inc. Nov 3, 2021 1 $0 4 Nov 5, 2021 Chief Operating Officer
ATHA Athira Pharma, Inc. Jun 14, 2021 0 $0 3 Jun 14, 2021 Chief Technology Officer